Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1020404

registered interest
date	05/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under the EU (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during the period covered by the Agreement.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199325
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 199327 question first answered 10/12/2018 14:12:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1020405

registered interest
date	05/12/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA) and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under EU Regulations (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during that period.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199326
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as an EU competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p><strong></strong><br><br></p><p> </p> answering member constituency Daventry answering member printed Chris Heaton-Harris question first answered 10/12/2018 15:48:34 answering member 3977 label Biography information for Chris Heaton-Harris
tabling member	1436 label Biography information for Paul Farrelly

1020408

registered interest
date	05/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: UK Notified Bodies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), whether the Department's response refers to (a) UK notified bodies licensed by the MHRA and (b) UK notified bodies that have also secured notified body status in other EU states.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199327
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 199325 question first answered 10/12/2018 14:12:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1016320

registered interest
date	28/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the transition period set out in the agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, whether the Medicines and Healthcare Products Regulatory Agency will retain its status as a competent authority; and whether existing CE marks assigned under that agency will be valid from 29 March 2019 until the end of that transition period.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	196736
answer	answer is ministerial correction date of answer 03/12/2018 answer text <p>The agreement of an implementation period will ensure that access to medicines and medical devices continues, and patient safety is maintained, in both the United Kingdom and European Union markets.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be the UK competent authority during this period.</p><p> </p><p>For medical devices, CE marks are assigned by notified bodies (rather than competent authorities such as the MHRA), and during the implementation period UK notified bodies will continue to conduct third-party conformity assessment in the UK, and the results of these tests will continue to be used and recognised for both the UK and EU markets.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 03/12/2018 18:29:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1012292

registered interest
date	22/11/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Copyright: EU Action
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the Trilogue process in relation to the EU Directive on Copyright in the Digital Single Market, whether the Government plans to support the inclusion of provisions to ensure that creators receive fair remuneration for the use of their works.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	194603
answer	answer is ministerial correction date of answer 27/11/2018 answer text <p>The Government supports the principle that creators should be fairly rewarded for their work whilst ensuring that we continue to encourage investment in new content and innovative services. We are engaging with our European partners to achieve these aims during Trilogue negotiations on this Directive.</p> answering member constituency East Surrey answering member printed Mr Sam Gyimah question first answered 27/11/2018 14:50:26 answering member 3980 label Biography information for Mr Sam Gyimah
tabling member	1436 label Biography information for Paul Farrelly

1012293

registered interest
date	22/11/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Copyright: EU Countries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential effect of the UK leaving the EU on the reciprocal relationships the UK has with the EU that enable collective management organisations to collect royalties from EU countries and distribute to creators in the UK.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	194604
answer	answer is ministerial correction date of answer 27/11/2018 answer text <p>The Government has considered this issue in the context of its Brexit analysis. It has concluded that the reciprocal arrangements between UK Collective Management Organisations (CMOs) and EU CMOs to collect royalties from EU countries and distribute to creators in the UK are private commercial agreements which are expected to continue after the UK has exited the European Union.</p> answering member constituency East Surrey answering member printed Mr Sam Gyimah question first answered 27/11/2018 15:43:32 answering member 3980 label Biography information for Mr Sam Gyimah
tabling member	1436 label Biography information for Paul Farrelly

1012294

registered interest
date	22/11/2018
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Arts: EU Grants and Loans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether the Government plans to remain part of Creative Europe after the current funding period concludes in 2020.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	194605
answer	answer is ministerial correction date of answer 27/11/2018 answer text The UK will always be a European country that advocates for cultural diversity as part of its global identity and is committed to continuing its contribution to and support of European culture. The Government has been clear that will be explore participation in any successor programme to Creative Europe. Where EU funding programmes are to the UK and EU's joint advantage, we want to discuss continued participation as part of the negotiations. Ultimately, the decision on which programmes are in the UK’s interests will be decided as part of the future partnership negotiations, which are ongoing. answering member constituency Stourbridge answering member printed Margot James question first answered 27/11/2018 19:18:35 answering member 4115 label Biography information for Margot James
tabling member	1436 label Biography information for Paul Farrelly

1010153

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 October 2018 to Question 177617 on Eating disorders, if he will list the 70 new or extended community services providing specialist community-based care for eating disorders that are open or in development by the local authority in which they are based.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	192754
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>This information is not available by local authority.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/11/2018 17:42:15 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

984726

registered interest
date	10/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which clinical commissioning groups do not commission specialist eating disorder services for people aged 18 and over (a) in the community and (b) as in-patient services.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	177617
answer	answer is ministerial correction date of answer 16/10/2018 answer text <p>This information is not held centrally.</p><p> </p><p>Specialist in-patient eating disorder services for people aged over 18 are commissioned by NHS England. Specialist community services for people aged over 18 with eating disorders are commissioned by clinical commissioning groups (CCGs). NHS England does not hold information about all of the specific services commissioned by individual CCGs.</p><p> </p><p>We know that early intervention is vital and can prevent problems continuing into adulthood, that is why in 2015 the Government introduced waiting time targets to improve access to eating disorder services for children and young people.</p><p> </p><p>The Government is also investing £150 million to expand eating disorder community-based care and as a result 70 dedicated new or extended community services are now either open or in development. This means at least 3,350 children and young people a year will receive swift, effective eating disorder treatment in the community.</p> answering member constituency West Suffolk answering member printed Matt Hancock question first answered 16/10/2018 14:18:59 answering member 4070 label Biography information for Matt Hancock previous answer version 78285 answering member constituency West Suffolk answering member printed Matt Hancock answering member 4070 label Biography information for Matt Hancock
tabling member	1436 label Biography information for Paul Farrelly

943859

registered interest
date	18/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the recommendations of the report Ignoring the alarms: How NHS eating disorder services are failing patients, published by the Parliamentary and Health Service Ombudsman in December 2017, what progress Health Education England has made on tackling the gaps in the provision of (a) education, (b) training and (c) numbers of eating disorder specialists in the NHS.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	165489
answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>The Government takes seriously the Parliamentary and Health Services Ombudsman (PSHO) report: ‘Ignoring the alarms: how NHS eating disorder services are failing patients’.</p><p> </p><p>In response to the PHSO report, NHS England have convened a working group with NHS Improvement, Health Education England (HEE), the Department and other partners to address the recommendations and take them into account in planning for improvements to eating disorder services.</p><p> </p><p>HEE is reviewing its current education and training offer and will work with subject matter experts to scope existing evidence-based practice to inform any new education and training resources. HEE is also considering how the capacity of the existing workforce may be used more innovatively and is exploring workforce planning interventions that can increase specialism in the field of eating disorders.</p><p> </p><p>The National Institute for Health and Care Excellence has run a consultation on the quality standard on eating disorders, which included two statements aimed at improving co-ordination of care. The quality standard is currently in its final stages of internal review and is expected to be published in September 2018.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 165491 165492 question first answered 23/07/2018 16:11:16 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly